Growth Factor Research and Why Growth Factors Have Performed Poorly in Clinical Trials

Growth factors are critical to bone regeneration, but biology does not work by simply adding one signaling molecule and expecting bone to grow. Regeneration depends on a coordinated cellular environment in which timing, dose, vascularity, delivery, and multiple signaling pathways work together. That distinction helps explain why growth factors can appear remarkably powerful in the laboratory yet produce far less predictable results when translated into clinical use.
BMP-7 (bone morphogenic protein 7)
OP-1(BMP-7) in collagen carrier showed only one out of three sinus augmentations producing enough bone for implant placement after 6 months.
BMP-2 (bone morphogenic protein 2)
BMP-2 produced inferior results for sinus augmentation when compared to other graft materials. 21% of sinus lifts failed and implants could not be placed. Of the implants placed, 18% failed within 6 months of loading.
BMP-2 stimulates both osteoblasts and osteoclasts
J Bone Miner Res. 2009 Nov;24(11):1917-26. doi: 10.1359/jbmr.090507. PMID: 19419314; PMCID: PMC2765934.
PDGF (platelet derived growth factor)
Tissue Eng Part A. 2010 Mar;16(3):983-93. doi: 10.1089/ten.TEA.2009.0230. PMID: 19839721.
PDGF stimulates mesenchymal stem cell proliferation but does not stimulate mesenchymal stem cells toward osteogenic differentiation and also does not stimulate factors involved in osteogenesis.
Recombinant Human Platelet-derived Growth Factor (rhPDGF-BB)
PDGF when applied to beta tricalcium phosphate results in no clinical attachment gain over beta tricalcium phosphate alone and equal bone regeneration after 3 years.
Why Growth Factors Perform Poorly in Clinical Trials
  • Growth factor half-life in intercellular fluid is between seconds to minutes depending on the growth factor.
  • Cell membrane receptors for growth factors are limited, therefore, applying additional growth factor molecules will not increase cell response.
  • Creating a tissue requires a very large number of molecules to be present at a specific time, concentration, and sequence to create normal tissue. A single growth factor is a very minor part of a regenerating tissue.
  • Due to immune reaction to the foreign growth factor, many growth factors can only be used one time in a patient and cannot be used if pregnant or will become pregnant within one year.